Recommended

Register now: Enhancing biopharma workflows with the power of UV/Vis spectroscopy webinar
Join us as we look at how the outsourcing of buffers is helping biopharma drug manufacturers to streamline their processes.
Learn more about leveraging real-world data, the practical applications of AI and adopting configurable LC/NC solutions.
Download this compendium to discover how hot-melt extrusion can help to overcome pharmaceutical formulation challenges
This Guide to Testing explores the limits of detection requirements for microbial testing of short-shelf-life products and sustainable endotoxin testing.
Join this webinar to hear about the latest RMM technology and how it aligns with UPS testing criteria.
Advertorial

Quotient Sciences launches as the new global identity for Quotient Clinical

Posted: 15 November 2017 | | No comments yet

Quotient Clinical, the drug development services organisation, announces its renaming to Quotient Sciences (Quotient), following the acquisitions of Co-Formulate, QS Pharma and SeaView Research…

Global-handshake

This new identity signifies a global footprint and an extended range of services, and symbolises the commitment to ensuring a consistent and high-quality experience for customers.

With 700 employees and five operating sites across the United States and the United Kingdom, Quotient is focused on delivering a portfolio of innovative services encompassing formulation development, clinical trial and commercial manufacturing, and clinical pharmacology.

Quotient’s Translational Pharmaceutics® platform integrates formulation development, real-time adaptive GMP manufacturing and clinical research, transforming the traditional industry approach of outsourcing to independent contract development and manufacturing organisations (CDMOs) and contract research organisations (CROs). Translational Pharmaceutics is proven to accelerate development timelines and reduce overall costs.

“We are excited about the future of Quotient Sciences,”

said Mark Egerton, CEO, Quotient Sciences.

“By integrating services typically found in disparate CDMOs and CROs, we break down barriers and support our customers to improve R&D productivity and accelerate the delivery of new medicines to patients around the world. We have a 30-year track record of service to a global customer base, including large multinational pharmaceutical companies to smaller virtual biotech organisations.” 

To learn more about Quotient Sciences, stop by booth #1443 for the unveiling event at the 2017 Annual Meeting and Exposition of the American Association of Pharmaceutical Scientists (AAPS) at 10.30am PST on Monday 13 November, in San Diego, California. Meet Quotient’s scientific leadership team and find out how Translational Pharmaceutics works to accelerate the speed of science.

For more information, visit quotientsciences.com